LSV Asset Management Sells 225,200 Shares of The Chemours Company (NYSE:CC)

LSV Asset Management lessened its stake in shares of The Chemours Company (NYSE:CC - Free Report) by 8.7% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 2,365,400 shares of the specialty chemicals company's stock after selling 225,200 shares during the period. LSV Asset Management owned 1.59% of Chemours worth $74,605,000 as of its most recent SEC filing.

A number of other institutional investors also recently modified their holdings of CC. Bank of New York Mellon Corp lifted its holdings in shares of Chemours by 11.0% during the third quarter. Bank of New York Mellon Corp now owns 6,196,063 shares of the specialty chemicals company's stock worth $173,800,000 after buying an additional 612,071 shares during the last quarter. Massachusetts Financial Services Co. MA boosted its holdings in Chemours by 10.0% in the 3rd quarter. Massachusetts Financial Services Co. MA now owns 3,160,740 shares of the specialty chemicals company's stock valued at $88,659,000 after purchasing an additional 286,076 shares during the period. Deutsche Bank AG grew its position in Chemours by 4,407.9% in the 3rd quarter. Deutsche Bank AG now owns 1,759,419 shares of the specialty chemicals company's stock worth $49,352,000 after purchasing an additional 1,720,389 shares during the last quarter. American Century Companies Inc. grew its position in Chemours by 0.7% in the 3rd quarter. American Century Companies Inc. now owns 1,459,463 shares of the specialty chemicals company's stock worth $40,938,000 after purchasing an additional 10,075 shares during the last quarter. Finally, Vaughan Nelson Investment Management L.P. increased its holdings in shares of Chemours by 2.2% during the 4th quarter. Vaughan Nelson Investment Management L.P. now owns 1,381,801 shares of the specialty chemicals company's stock worth $43,582,000 after purchasing an additional 29,475 shares during the period. Institutional investors own 76.26% of the company's stock.

Chemours Price Performance

Shares of Chemours stock traded up $0.42 during midday trading on Friday, hitting $26.57. 1,709,363 shares of the company were exchanged, compared to its average volume of 1,149,144. The firm has a 50 day simple moving average of $26.47 and a 200-day simple moving average of $27.85. The Chemours Company has a 52 week low of $15.10 and a 52 week high of $39.05. The firm has a market cap of $3.96 billion, a P/E ratio of -12.24 and a beta of 1.99. The company has a debt-to-equity ratio of 5.26, a current ratio of 1.61 and a quick ratio of 1.00.

Chemours (NYSE:CC - Get Free Report) last announced its quarterly earnings results on Tuesday, April 30th. The specialty chemicals company reported $0.32 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.25 by $0.07. The firm had revenue of $1.35 billion during the quarter, compared to the consensus estimate of $1.35 billion. Chemours had a negative net margin of 5.51% and a positive return on equity of 46.67%. The firm's quarterly revenue was down 12.1% on a year-over-year basis. During the same period last year, the firm posted $0.98 EPS. Research analysts forecast that The Chemours Company will post 2.16 earnings per share for the current year.

Chemours Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, June 14th. Investors of record on Wednesday, May 15th will be given a dividend of $0.25 per share. The ex-dividend date of this dividend is Tuesday, May 14th. This represents a $1.00 annualized dividend and a yield of 3.76%. Chemours's dividend payout ratio (DPR) is -46.08%.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently weighed in on the company. UBS Group lifted their target price on Chemours from $21.00 to $28.00 and gave the stock a "neutral" rating in a research report on Tuesday, April 2nd. Barclays decreased their price objective on Chemours from $32.00 to $30.00 and set an "equal weight" rating on the stock in a report on Tuesday, April 2nd. Finally, BMO Capital Markets upgraded Chemours from an "underperform" rating to an "outperform" rating and upped their target price for the company from $19.00 to $34.00 in a research note on Tuesday, April 9th. Seven equities research analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock. Based on data from MarketBeat, Chemours has an average rating of "Hold" and an average target price of $31.63.

Chemours Company Profile

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure brand for delivering whiteness, brightness, opacity, durability, efficiency, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging.